IMRIS Inc. (IMRIS) designs, manufactures and markets the VISIUS Surgical Theatre, a multifunctional surgical environment that provides intraoperative vision to clinicians. Designed to enable hospital's clinical application needs, the VISIUS Surgical Theatre can incorporate magnetic resonance (MR) imaging, computed tomography (CT) imaging and x-ray angiography in a number of configurations to provide intraoperative images of diagnostic quality. IMRIS sells the VISIUS Surgical Theatres globally to hospitals that deliver clinical services to patients in the neurosurgical, cerebrovascular and cardiovascular markets. The VISIUS Surgical Theatre incorporates magnetic resonance imaging, CT and fluoroscopy into multi-purpose surgical suites to provide truly intra-operative imaging for specific medical applications.
|Headquarters||100, 1370 Sony Place|
WINNIPEG, MB, Canada R3T 1N5
|Chairman of the Board, Chief Executive Officer||H. David Graves|
|President, Chief Operating Officer||Jay Miller|
|Chief Financial Officer, Executive Vice President - Finance & Administration, Secretary||Kelly McNeill|
|Executive Vice President - Global Sales||Mark Reade|
|Executive Vice President - Marketing||Amy Boyle|
With TD Waterhouse, you have access to the industry's leading selection of independent research reports from providers such as TDSI, TD Securities, S&P, INK and Argus.
|Shares Out.||--||Book Value||--|
|Annual Dividend Rate||$0.00||Price/Sales (TTM)||--|
|Ex-Div Date||1/1/01||P/Cash Flow (TTM)||--|
|Pay Date||1/1/01||Operating Margin||--|
*GAAP = prior to non-GAAP analyst adjusted earnings.